Mar­i­nus com­pletes its turn­around with first ap­proval of sole drug, win­ning a PRV for its ef­forts

Af­ter a long and wind­ing road, Mar­i­nus Phar­ma­ceu­ti­cals has achieved FDA ap­proval for its sole drug.

The biotech an­nounced Fri­day af­ter­noon that reg­u­la­tors OK’d ganax­olone …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER